Treatment of herpes simplex keratitis: comparison of acyclovir and vidarabine. 1984

W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé

At three university centres 66 patients presenting with herpetic dendritic or geographic ulcers participated in a double-blind comparative study of 3% acyclovir and 3% vidarabine ointment. There was healing in 31 (97%) of the 32 patients treated with acyclovir, in a mean time of 6.3 days, and in 30 (88%) of the 34 treated with vidarabine, in a mean time of 7.1 days. The two medications were statistically equally effective, no difference being demonstrated in the healing rate, in the frequency of punctate epithelial keratitis or stromal keratitis, or in the final visual acuity.

UI MeSH Term Description Entries
D007635 Keratitis, Dendritic A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed) Furrow Keratitis,Keratitis, Furrow,Dendritic Keratitides,Dendritic Keratitis,Furrow Keratitides,Keratitides, Dendritic,Keratitides, Furrow
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U

Related Publications

W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
July 1982, The American journal of medicine,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
December 1981, American journal of ophthalmology,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
January 1981, Transactions of the American Ophthalmological Society,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
July 1987, Klinische Monatsblatter fur Augenheilkunde,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
January 1985, Scandinavian journal of infectious diseases. Supplementum,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
May 1976, American journal of ophthalmology,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
March 1991, Archives of ophthalmology (Chicago, Ill. : 1960),
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
May 1983, The Journal of infection,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
January 1986, The New England journal of medicine,
W B Jackson, and C W Breslin, and D W Lorenzetti, and R Michaud, and I Dubé
September 1978, Annals of ophthalmology,
Copied contents to your clipboard!